No Data
Meihao Medical (301363.SZ): has repurchased 0.48% of shares in total.
On January 3, Glonghui reported that Meihai Medical (301363.SZ) announced that as of December 31, 2024, the company has repurchased a total of 1,968,851 shares through its special securities repurchase account via centralized bidding trading, accounting for 0.4842% of the company's total share capital, with a highest Fill Price of 28.31 yuan/share, a lowest Fill Price of 22.80 yuan/share, and a total transaction amount of 50.0937 million yuan (excluding transaction fees).
An Intrinsic Calculation For MeHow Innovative Ltd. (SZSE:301363) Suggests It's 20% Undervalued
Mei Hao Medical (301363.SZ): Malaysia's self-owned production bases Phase 1 and Phase 2 have been put into operation.
On November 27, Gelonghui reported that Meihao Medical (301363.SZ) stated on the investor interaction platform that the main foreign sales countries are currently Singapore, Australia, and others. The company has its own production base in Malaysia, with the first and second phases already in production, and the third phase under construction, meeting the needs of different clients in various supply chain markets.
Returns On Capital Signal Tricky Times Ahead For MeHow Innovative (SZSE:301363)
Meihao Medical (301363.SZ): The cumulative repurchase of 0.4842% of the shares.
格隆汇 November 4th | Meihao Medical (301363.SZ) announced that as of October 31, 2024, the company has repurchased a total of 1,968,851 shares of the company through a designated securities account using centralized auction trading method, accounting for 0.4842% of the total share capital. The highest fill price was 28.31 yuan/share, the lowest fill price was 22.80 yuan/share, and the total fill amount was 50,093,656.31 yuan (excluding transaction costs).
Beautiful Healthcare: 2024 Third Quarter Report
Mehow Innovative Ltd.'s (SZSE:301363) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?
